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In this communication, we report on poly(amido amine) dendrimers (PAMAM) as coupling agents for 
recombinant single-chain (ScFv) antibodies to nanoparticle (NP) labels, for use in immunoassay. We 
present a simple theory for the kinetics of particle capture onto a surface by means of an antibody-antigen 
reaction, in which the important parameter is the fraction of the particle surface that is active for reaction.  10 
We describe how increasing the generation number of the linking dendrimer significantly increased the 
fraction of the NP surface that is active for antigen binding and consequently also increased the assay 
kinetic rates. Use of dendrimers for conjugation of the NP to the antibody resulted in a significantly 
higher surface coverage of active antibody, in comparison with mono-valent linker chemistry. As a direct 
consequence, the increase in effective avidity significantly out-weighed any effect of a decreased 15 
diffusion coefficient due to the NP, when compared to that of a molecular dye-labelled antibody.  The 
signal to noise ratio of the G4.5 dendrimer-sensitised nanoparticles out-performed the dye-labelled 
antibody by approximately four-fold. Particle aggregation experiments with the multi-valent antigen CRP 
demonstrated reaction-limited aggregation whose rate increased significantly with increasing generation 
number of the dendrimer linker. 20 
Introduction 
 The context of this work involves the development of cardiac 
biomarker ‘point of care’ testing, which is predominantly based 
upon rapid immunoassay methods.1 The need for such 
development is emphasised by the fact that almost half of the 25 
events associated with cardiovascular disease (CVD) occur 
without symptoms,2 while CVD is the cause of nearly half of all 
deaths in the western world.  It is essential to maximise the signal 
to noise ratio to achieve clinically relevant sensitivity and limits 
of detection in biomedical diagnostic devices 3.  Simple assay 30 
designs involve first capturing an antigen onto a surface using 
one antibody, then measuring the surface concentration by 
visualising the captured antigen through its reaction with a 
second, labelled antibody. Owing to their intense signal, 
fluorescent nanoparticles (NP) are useful as labels since they can 35 
be measured directly, without the need for any amplification step 
4-11
. NP labels can, however, suffer from disadvantages in 
comparison with simple molecular labels, most notably effects 
due to particle aggregation12 and the related effect of non-specific 
binding 13 to the capture surface. The benefits of using NPs can 40 
only be realized if they are efficiently coated with detection 
antibody, have good colloidal stability and the ratio of specific to 
non-specific binding (NSB) is sufficiently great. Another issue in 
the use of NPs as labels is the fraction of the coupled antibody 
that is in fact active or available for reaction with antigen 14, 15. 45 
This fraction can be rather small, which in turn can lead to 
diminished sensitivity and increased non-specific binding. The 
minimisation of NSB is essential for sensitive detection in an 
assay16. Thus, it is clear that the strategy used to attach an 
antibody to NP surface is a key element that affects the activity of 50 
the bound antibody, the non-specific binding and the surface 
binding of particles.  
 Improved colloidal stability of silica NPs has been previously 
achieved by the addition of negatively charged non-reactive 
organosilanes in addition to organosilanes with functional groups 55 
available for bio-immobilisation12. The number of attachment 
sites on the nanoparticle surface is limited in order to maintain 
the suspension stability of the NP system. For this reason it is 
difficult to achieve high protein coupling ratios. We have recently 
demonstrated some advantages of using multivalent molecules 60 
such as dendrimers as antibody coupling scaffolds as illustrated 
on fig. 1.17 We have reported that good control over the colloidal 
stability of the NPs in the conjugation process can be achieved by 
using dendrimers as linkers. The use of dendrimers with COOH 
terminal groups had a positive effect on the monodispersity of the 65 
reaction mixture by maintaining a negative zeta potential of the 
individual particles. As a result, we were able to improve assay 
sensitivity and limits of detection, when compared to other NP 
samples prepared by using common homo- or hetero-functional 
bilinkers. 70 
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One of the specific reasons for exploiting antibody-sensitized dye 
doped nanoparticles as the next generation labels is their use in 
inexpensive and rapid, point-of-care biomedical diagnostics 
devices. In this context, the obvious questions we needed to 
address were: i) what is the effect of the low diffusion coefficient 5 
of such large, dense fluorescent labels on the assay kinetics and 
how does the binding rate constant compare with the dye-labelled 
antibody?; and ii) what is the correlation between the active 
fraction area of NPs, varied by the use of different generation of 
dendrimer, and the effect of NSB to the capture surface?  10 
In this communication we present a simple kinetic theory for 
particle capture onto an antigen-loaded surface and compare the 
effect of using 4 sequential dendrimer generations to conjugate 
proteins to silica NPs containing a NIR fluorescent dye in their 
core. We used as our model an assay for the stable biomarker C-15 
reactive protein, CRP, whose serum concentration can increase 
10,000-fold during cardiovascular inflammation.18 We 
demonstrate significant improvements in the antigen-recognition 
activity of dendrimer-sensitised NPs, which correlates directly 
with the generation number used for coupling and is consistent 20 
with the theory. We also show that the use of dendrimers as the 
coupling agents reduces NSB effects to less than the level 
exhibited by a molecular fluorophore-labelled antibody.  The 
overall effect is a significantly improved signal/background ratio. 
 25 
Fig. 1 (A) A cartoon showing the bioconjugation reaction between the 
nanoparticles and the recombinant single chain fragments (ScFv) of anti-
CRP mediated by PAMAM dendrimers, (B) an illustration of a direct 
binding assay we used to demonstrate that increasing the active surface 
area of the NP leads into increase in assay kinetic rates and (C) a graphic 30 
representation of the sensitized nanoparticle aggregation assay, induced 
by the introduction of the CRP antigen. 
 
Materials and Methods 
Triton® X-100 (trademark Union Carbide), n-hexanol (anhydrous, 35 
>99%), cyclohexane (anhydrous 99.5 %), ammonium hydroxide 
(28 % in H2O > 99.99 %), tetraethylorthosilica (TEOS, 99.99 %), 
aminopropyltriethoxysilane (APTES, 99 %), 3-
(trihydroxysilyl)propyl methyl phosphonate, monosodium salt 
solution (THPMP, 42 wt % in water), absolute ethanol, 40 
monobasic sodium phosphate, dibasic sodium phosphate. 
phosphate buffered saline (PBS, pH 7.4, 0.01 M), Tween ® 20 
(trademark Uniqema), sodium azide (99.99 %), PAMAM 
dendrimers (-COONa surface groups), generations 1.5, 2.5, 3.5 
and 4.5 (with diameters ranging from 1.5-4 nm) and albumin 45 
from bovine serum (BSA, 98 %) were all purchased from Sigma 
Aldrich Ireland, and used without further purification. Black 96 
well plates used in the immunoassay were purchased from AGB 
Scientific Ireland. Deionised water (>18 MΩ) was obtained from 
a Milli-Q system from Millipore Ireland. The microwell plates 50 
with array of 5 × 15 wells (Vwell = 10µL) were custom made by 
Micronit Microfluidics (Enschede, The Netherlands). 
The dye used in this work is 4,5-Benzo-1'-ethyl-3,3,3',3'-
tetramethyl-1-(4-sulfobutyl) indodicarbocyanin-5'-acetic acid N-
succinimidyl ester, or more commonly referred to as NIR-664-N-55 
succinimidyl ester (purchased from Sigma Aldrich). This dye has 
a quantum efficiency of 23 %, a molar absorptivity of 187,000 L 
mol-1 cm-1 and fluorescence excitation and emission wavelengths 
of 672 nm and 694 nm, respectively, in isopropanol. 
Monodisperse nanoparticles 80 nm in diameter, loaded with the 60 
NIR-664-N-succinimidyl ester fluorophore were prepared as 
previously described. 17 
Anti-C-reactive protein (CRP)/green fluorescent protein 
(GFP) – Nanoparticle coupling 
Conjugation - PAMAM dendrimers (-COOH surface groups), 65 
generations 1.5, 2.5, 3.5 and 4.5 were first activated with 1-Ethyl-
3-[3-dimethylaminopropyl]carbodiimide Hydrochloride (EDC) / 
N-hydroxysulfosuccinimide (sulfo-NHS) mixture in 0.1 M 2-(N-
morpholino)ethanesulfonic acid (MES) buffer, pH 4.5 before 
reacting with the protein. As an example, PAMAM G1.5 (1 µmol, 70 
16x -COOH) was dissolved in 0.5 ml of MES buffer. To this 
solution, sulfo-NHS (24 µmol, 1.5 equiv. per one -COOH group) 
and EDC (96 µmol, 6.0 equiv. per one –COOH group) were 
added; the final volume adjusted to 1 ml with MES buffer and the 
reaction was allowed to proceed for 15 minutes at room 75 
temperature. The NHS-activated dendrimer was then directly 
added into the NPs (2mg/ml), while keeping the total volume at 1 
ml. This mixture was allowed to react for 30 minutes; 
subsequently, the excess of solution containing unreacted, free 
dendrimer was removed by centrifugation (15000 rpm, 5 80 
minutes). The dendrimer-modified NPs were re-suspended in 
MES buffer, pH 4.5 and the protein, either recombinant single-
chain fragment anti-CRP antibody (26kDa) 19 or green fluorescent 
protein (135 µg) was added. The reaction mixture was gently 
shaken for 4 hours at r.t., 100 µl of MES buffer, pH 12.0, added 85 
to hydrolyze the remaining NHS esters and the mixture was 
purified by centrifugation (4x, 15000 rpm, 5 minutes).  The NP–
protein bioconjugate was re-suspended in 0.1 M PBS buffer, pH 
7.4, with 0.01 %(w/v)  NaN3 and 0.5 % (w/v)  of bovine serum 
albumin (BSA). All reactions involving NPs were performed 90 
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under reduced light conditions (reaction vessels wrapped up in 
aluminum foil) to prevent photo-bleaching and all final samples 
were stored in the dark at 4 °C before they were used in 
immunoassays. 
Longer term storage – For NP samples that are to be stored for 5 
longer than 30 hours before they are used in immunoassays or for 
shipping purposes, we highly recommend to aliquot the final 
solution into smaller 100-200 µL fractions and freeze dry them 
under reduced light. The shelf-life of the antibody-sensitized NPs 
can be thus significantly extended as supported by data shown in 10 
supporting information (ESI 1). 
Fluorescence measurements 
Direct binding assay - A 75 well plate was oxidized in oxygen 
plasma. The oxidation took place during 6 min in a plasma 
chamber (400 Plasma System) at a working pressure of 0.26 15 
mbar, 1000 W and with a flow of oxygen at 100 ml/min. To 
adsorb antigen onto the surface for the particle-binding 
measurement, 5 µl of the penta-valent antigen, CRP (50 µg/ml) 
solution, was loaded into each well and incubated at 37 °C for 
two hours. The surface was then washed 1x with PBS containing 20 
Tween 20 (0.2 %, v/v) and further 1x with PBS. The plate was 
subsequently immersed in a PBS solution containing BSA (1 %, 
w/v) for one hour. For the assay kinetics determination, after 
rinsing the wells with PBS (1x) and drying under a stream of N2, 
anti-CRP – NP biocojugates were added (5 µl of a 0.1 mg/ml 25 
suspension: 0.25nM assuming a density of 2.4 g.cm-3 20 and 
diameter of 80nm) and incubated at 37° C for various time. The 
plate was subsequently washed with PBS Tween (0.2 % v/v) 
solution 2x, with PBS once and dried under a stream of N2. 
Fluorescence measurements were performed on a Safire (Tecan) 30 
microplate reader. For NIR-doped NPs, the excitation and 
emission wavelengths were set at 672 and 700 nm, respectively. 
The data were fitted using a power function according to equation 
6. The non-specific binding was determined by extrapolation 
from the fitted curve at the time t=0. 35 
NP surface activity assessment - GFP was conjugated to the NP 
surface using PAMAM dendrimers, generations 1.5 – 4.5 as 
described in the ‘Anti-CRP/GFP – Nanoparticle coupling’ 
section. The average surface coverage was measured by means of 
fluorescence. The emission of GFP (508 nm) was clearly 40 
distinguishable from that of the NPs, which have emission 
maximum at 702 nm. A calibration curve of GFP fluorescence at 
8 different concentrations was constructed. The amount of bound 
GFP was calculated based on the known fluorescence yield per 
molecule21, 22 and converted to an area using the known 45 
dimensions of GFP. These figures then allowed the fractional 
surface coverage to be calculated using the known dimensions of 
the dendrimer. 
Measurement of equilibrium constant for antibody binding to 
the antigen-sensitised reaction well -  The equilibrium constant 50 
was estimated by measuring the fluorescence signal at 
equilibrium, resulting from incubation of the CRP-sensitised 
surface with lissamine rhodamine-labelled anti-CRP ScFv. 
Briefly, a 75 well plate was oxidized in oxygen plasma as 
described above. To load antigen onto the surface for the particle-55 
binding measurement, 3 µl of the penta-valent antigen, CRP (50 
µg/ml) solution, was loaded into each well and incubated at 37 °C 
for two hours. The surface was then washed 1 × 10 min with PBS 
containing Tween 20 (0.2 %, v/v) and further 1 × 5 min with 
PBS. The plate was subsequently immersed in a PBS solution 60 
containing BSA (1 %, w/v) for one hour. After rinsing with PBS 
(1 × 10 min), water (1 × 5 min) and drying under a stream of N2, 
lissamine rhodamine-labelled anti-CRP was added at 
concentrations ranging from 0.1 ng/mL to 100000 ng/mL, in 10-
fold serial dilutions. The 75 well plate was then incubated at 37° 65 
C for 1 hour. The plate was subsequently washed with PBS 
Tween (0.2 % v/v) solution 2 × 10 min, with PBS 1 × 5 min and 
dried under a stream of N2. Fluorescence measurements were 
performed on a Safire (Tecan) microplate reader. The signal fitted 
to a Langmuir isotherm, with surface binding equilibrium 70 
constant (9.5±2) × 105M-1 (as shown in Online Resource 1).  The 
measurement highlighted significant variability of the capture 
plate surface preparation.   
Dynamic Light Scattering (DLS) measurements 
All NP dispersions were analysed at a nanoparticle concentration 75 
of 1mg/ml in water. The stability of the dispersions was 
monitored at 25 °C over a period of 3 hours with the average of 
50 measurements taken at two minute intervals. For the antigen -
mediated NP aggregation studies, 1µl of CRP solution (at a 
concentration of 2.42mg/ml in PBS) was introduced to the 80 
nanoparticle dispersion (1ml). The DLS measurement was 
immediately started without further perturbation of the 
dispersion. All measurements were performed in duplicate with 
two different batches of sensitized NPs. 
Theory of nanoparticle capture onto a surface by 85 
an antibody-antigen reaction 
A surface capture immunoassay can be considered in two ways: 
either incubation of antibody-sensitised particles with antigen 
followed by capture onto an antibody-sensitised surface of those 
particles that have bound antigen; or capture of antigen onto an 90 
antibody-sensitised surface followed by capture of antibody-
sensitised particles onto the surface-bound antigen.  In either 
case, the kinetics of reaction of a sensitised particle with a 
sensitised surface is a key element of the description of the 
process and hence of the assay design23, 24. The size of the 95 
particles and the fraction of the particle surface that is active for 
the antibody-antigen reaction are the important parameters.  In 
the present work, we have studied the capture of particles onto an 
antigen-loaded surface, thus focussing on the second stage of the 
process, and for simplicity we have studied just one coverage of 100 
antigen on the capture surface since our aim has been to elucidate 
the effect of the linker on the activity of the particles in the assay.  
We have developed a simple kinetic model for particle capture 
onto an antigen-loaded assay surface by means of an antibody-
antigen reaction. This is similar to kinetic formulations treating 105 
single molecules25, 26, but also accounts for the fact that each 
particle has a multiplicity of antibodies present on its surface. The 
NPs-surface-bound antibodies can be considered as active 
binding sites. Depending on the coverage of such active sites on 
the particle, a collision of the particle with an antigen may or may 110 
not lead to reaction, with a probability proportional to the surface 
coverage of active sites on the particle and the surface coverage 
of antigen in the reaction well. 
The capture reaction, of antibody-functionalised NPs onto the 
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assay surface, can be written as: 
P + S   PS          (1) 
with forward rate constant kon and reverse rate constant koff. Here, 
S denotes an active antigen site on the assay capture surface. If 
the NP is bound to the surface by a single antibody-antigen 5 
interaction, then koff will simply be the dissociation rate constant 
for the antigen-antibody complex. The association rate, kon, will 
be determined by the probability of a reactive collision between 
an antibody functionalised NP and an unoccupied reactive 
antigen site on the assay surface. A reactive collision, leading to 10 
coupling of the NP to the assay surface, would occur when a 
reactive part of the NP surface (an antibody, oriented with the 
binding site exposed) collides with a reactive part of the assay 
surface (an antigen, oriented with the epitope exposed). NPs are 
in a continuous state of collision with the assay surface, at a rate 15 
determined by the diffusion coefficient of the NPs (hence by their 
radius and the viscosity of the reaction medium) and by their 
concentration. In the absence of any forces favouring a particular 
orientation of the NP with respect to the assay surface during 
approach and collision, the probability that the collision will be 20 
with an active site on the NP surface will simply be the fraction 
of the NP surface area that is covered by active antibody. By 
‘active antibody’ is meant an antibody molecule oriented on the 
NP surface such that its binding site is exposed and available for 
reaction. The active antibody is only some fraction of the total 25 
antibody present on the NP surface, the fraction varying primarily 
with the surface coverage of antibody on the NP and dependent 
also on the means of attachment to the NP surface.  The active 
fraction could decrease drastically as total antibody loading on 
the surface increases26, 27. As the NP concentration on the assay 30 
surface builds up, particles not only occupy sites but also 
physically block the assay surface area, on account of their size.  
The probability of obtaining a successful reactive collision 
between particle and capture surface also depends on the fraction 
of the capture surface that is active for reaction. Therefore, the 35 
probability that the collision will be with an active site on the 
assay capture surface will be a product of the following: 
• The fraction of the total assay capture surface that is 
covered by accessible antigen with the binding epitope 
correctly exposed to facilitate antibody binding;  40 
• The fraction of the total assay surface that is unblocked 
by bound NPs;  
• A coverage-dependent factor that expresses the 
requirement that a NP requires a space whose smallest 
dimension is at least as large as the NP diameter, in 45 
order that the NP can fit into the space.   
This statement assumes that the approach and collision of 
nanoparticles is unaffected by the presence of previously bound 
NPs except insofar as these occupy surface area.  If koff is 
sufficiently low, then the requirement that NPs can fit into the 50 
spaces available leads to a limiting coverage – the ‘jamming 
limit’ - which is approximately 55% of the total surface area for 
random sequential irreversible adsorption of spherical objects. 27 
If the coverage of the assay capture surface by bound NPs is 
sufficiently low, then the effects of particles jamming the surface, 55 
and of other particle-particle interactions, can be ignored.  and the 
increase of NP coverage, and hence of surface-bound 
fluorescence will follow: 
     
(2) 60 
 
where c denotes the nanoparticle concentration in the solution at 
the capture surface and θ denotes the fraction of the total capture 
plate area that has been covered by particles: reaction can only 
occur on the un-covered area. The fraction of the total capture 65 
plate area that is obscured by a each particle depends on the size 
of the particle. Since the surface-bound fluorescence intensity, in 
the absence of self-quenching, will be proportional to the particle 
coverage θ :   I = Fθ ,  then the fluorescence intensity variation I  
will also follow: 70 
 
(3) 
  
If the surface capture reaction does not lead to a significant 
diminution of the particle concentration in the solution, so that c 75 
can be considered constant, then the first-order rate equation (4) 
results:  
    
(4) 
  80 
As coverage increases towards the jamming limit, then the rate of 
adsorption slows, shows an approximate power-law dependence 
on the surface coverage28 and also becomes dependent on the 
size29, charge30, 31and interaction potential32 of the captured 
particles. The effect of a slow desorption also would be to 85 
facilitate a slow rearrangement of the surface such that the 
coverage could further increase beyond the jamming limit. Also, 
if the capture rate were sufficiently great, then the concentration, 
c, of particles in the solution at the surface would decrease below 
that in the bulk solution, far away from the surface, and a 90 
complete description should therefore include the effect of NPs 
diffusion towards the capture surface. Although it is a relatively 
simple matter to extend the treatment to include these effects, in 
this paper we consider only the reaction-controlled limiting 
behaviour at low coverage, described by equation 4.  95 
The considerations of reaction probability that were discussed 
above are embedded in the capture rate constant, kon, which 
depends on both the fraction of the surface of the antigen-loaded 
capture plate that is in fact active for the capture reaction (that is, 
it depends on the surface state of the adsorbed antigen) and on the 100 
fraction of the surface of the antibody-sensitised NP that is active 
for reaction. It can be written  
     (5) 
 
where kD is the diffusion-limit rate constant for NP consumption 105 
by the antigen-surface, dependent on the NP radius and the 
viscosity of the medium, ε is the reaction efficiency for a reactive 
collision, θS is the fraction of the capture surface area (here the 
antigen-loaded capture plate) that is active for the capture 
reaction, which in this case is dependent on the surface coverage 110 
of active adsorbed antigen on the prepared capture surface, and θP 
is the active fraction of the NP surface, in this case dependent on 
the surface coverage of active antibody attached to the NP.  The 
central objective of surface functionalisation with dendrimer is to 
increase θP.  We use eq 4 to deduce the dependence of the surface 115 
capture rate constant and hence θP on the generation number of
dθ
dt
= konc 1−θ( ) − koffθ
dI
dt
= Fkonc − I konc + koff( )
I = Fkonc
konc + koff





 1− exp − konc + koff( ) t( ){ }
kon = kDεθSθP
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Fig. 2 TEM images of  silica NPs, doped at 3 % w/v of NIR-664 dye, taken few days after the sample was made (left image) and one year after storing the 
sample in 0.01 M PBS buffer, pH=7.4 (right image).     
dendrimer used for surface functionalisation. We do not in this 
communication address the question of maximising θS though 
clearly the same techniques that we use to increase the surface 5 
activity of the particles could also be used to increase the surface 
activity of the plate. 
Results and Discussion 
 A successful conjugation reaction between the particle and 
antibodies requires good monodispersity and colloidal/chemical 10 
stability of the particles, often in buffered solutions with 
relatively high salt concentration. The NPs used in this work were 
prepared by reverse microemulsion method based on a water-in-
oil reverse microemulsion system. The optimal research scale of 
this method typically yields 20 – 30 mg of NPs per batch and we 15 
have previously reported on batch-to-batch uniformity and 
polydispersion fidelity33 (for additional information on batch-to-
batch variations related to particle surface modification, see ESI 
1). However, we also decided to elaborate on a longer term 
colloidal and chemical stability of the particles upon storage in 20 
aqueous solution. As demonstrated on figure 2, the reverse 
microemulsion method produces particles with low polydispersity 
index (left TEM image). Interestingly, after one year in 0.01 M 
PBS buffer, the particles retained reasonably good 
monodispersity (right TEM image). The particles showed a small 25 
degree of degradation and cross-bridging phenomenon, 
presumably due to hydrolysis and consequent polymerization of 
surface bound silanes. The bridges between the particles were 
easily broken by ultrasonication. In order to avoid the 
aforementioned degradation and potential loss of fluorescence 30 
intensity, we recommend freeze-drying the samples as mentioned 
in Materials and Methods. Freeze-drying proved to be an 
effective method for long term storage of even antibody-coated 
NPs (supporting information, ESI 2)  
 Another issue when preparing antibody-sensitized NPs is the 35 
purification of the reaction mixture. One of the simplest 
techniques to separate the antibody-coated NPs from the excess 
of unrected antibody is by a sequence of centrifugation-
ultrasonication steps. This method can introduce some degree of 
thermal stresses on the antibodies and may eventually 40 
compromise their activity. The desired level of purity is specific 
to an individual application. Complete removal of the excess 
antibody from the reaction mixture can be achieved after four 
washing steps. However, about 99% of the unreacted antibody is 
already removed after two centrifugations-ultrasonications 45 
(supporting information, ESI 3) 
 According to the theoretical model presented in this 
communication, the central objective is to increase the active 
surface area of the nanoparticles. Therefore,  we checked that the 
average number of active carboxylate functions available for 50 
reaction after dendrimer sensitisation of the NPs scaled as 
expected with the dendrimer generation number. Green 
Fluorescent Protein (GFP) was conjugated to the NP surface 
using PAMAM dendrimers, generations 1.5 – 4.5 and its surface 
coverage was then measured by means of fluorescence. The 55 
emission of GFP (508 nm) was clearly distinguishable from that  
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Fig. 3 Percentage of NP surface area covered with GFP after conjugation 
with four generations (1.5-4.5) of PAMAM dendrimers. 
 20 
of the NPs. The amount of bound GFP was computed using the 
known fluorescence yield per molecule22, 23 and converted to an 
area using the known dimensions of GFP.  These figures then 
allowed the fractional surface coverage to be calculated using the 
known diameter of the particles, augmented by the known 25 
dimensions of the dendrimer. Figure 3 illustrates the effect of 
dendrimer generation number on the amount of bound GFP 
protein.  As expected, the amount of GFP conjugated to the NP 
surface  increased with increasing generation number of the 
dendrimer employed as linker, scaling approximately as the 30 
number of carboxylate groups in the outer shell of the dendrimer: 
the conjugation with PAMAM 4.5 (containing 128 surface 
carboxylate groups) resulted in a nanoparticle-GFP complex with 
at least an 8-fold higher protein loading than the same reaction 
with the smallest dendrimer used, PAMAM 1.5 (containing 16 35 
surface carboxylate groups). 
In order to evaluate the effect of dendrimer generation number as 
a linker of antibodies to NPs, a direct binding fluorescence-linked 
immunosorbant assay (FLISA) was carried out. The antigen, 
CRP, was adsorbed onto the surface of microtitre plate wells.  40 
 
Fig. 4 Direct binding CRP assay curves for the nanoparticles sensitised 
with anti-CRP through PAMAM dendrimers. 
 
The ScFv antibody was coupled to the fluorescent NPs and the 45 
effect of dendrimer linker generation number on the kinetics of 
capture of NPs onto the surface was measured.  
Figure 4 shows the time variation of the relative fluorescence 
intensity from bound NPs. The only variable was the generation 
number of the linking dendrimer: the capture surface preparation 50 
and the NP concentration remained the same for all 
measurements.  
 
Table 1 Fitting parameters derived from curves in Fig. 4; and calculated 
kon rate constants for antibody coupled directly to DY645 dye and 55 
antibody-sensitized NPs with four generations of PAMAM dendrimer 
label Ilim Ioffset 105 kobs / s-1 kon / M-1s-1 
DY645 24.9 ± 3.1 16.3 ± 1.3 7.1 ± 1.9 70 ± 20 
NP-G1.5 26.4 ± 1.9 9.5 ± 1.0  10.0 ± 1.8 190 ± 60 
NP-G2.5 36.6 ± 2.1 7.7 ± 0.8 6.5 ± 0.75 210 ± 60 
NP-G3.5 43.5 ± 2.4 10.1 ± 0.9 5.9 ± 0.7 220 ± 70 
NP-G4.5 49.6 ± 3.2 15.5 ± 1.4 7.3 ± 1.0 280 ± 80 
 
In our interpretation we have treated any non-specific adsorption 
of the particles to the surface as a time-independent offset of the 
fluorescence signal and therefore have modified equation 4 as 60 
follows, for fitting to the time variation of the fluorescence: 
   
(6) 
                                    where kobs = konc + koff. We take Ioffset to 
represent a non-specific adsorption of the antibody functionalised 65 
particles. Its variation across the different dendrimer generations 
used as linkers, compared with its value for a simple dye-linked 
antibody, is shown in Fig. 5B. 
One of our objectives was to compare the performance of the 
antibody-dendrimer linker conjugated NP with that obtained 70 
using antibody coupled directly to the fluorescent dye rather than 
to the dye loaded nanoparticles. Thus, in figures 5A and 5B we 
present the reaction parameters acquired by the non-linear least 
square fitting of equation (6) to the experimental data for the 
dendrimer-antibody-conjugated NPs relative to those observed 75 
for an assay performed using dye-labeled antibody. The limiting 
value of relative fluorescence intensity at long time is: 
       
 
(7) 80 
 
The rate constant kobs is obtained directly from the fit (eq 6).  
Thus:  
F(konc) = kobs(Ilim,rel - Ioffset)         (8)  
The scaling factor, F, was the same for all measurements as was 85 
the particle concentration, c. Therefore the values of kon scaled 
relative to one another can simply be obtained from the relative 
values of the product kobs(Ilim,rel - Ioffset) and are shown in Fig. 5A.  
The relative ‘on’ rate, (kon)rel increased with increasing generation 
number of the dendrimer, consistent with the expected increase in 90 
the active surface area. The effect significantly out-weighed the 
I
rel = I lim,rel 1− exp −kobst( ){ }+ Ioffset
I lim,rel − Ioffset( ) = F konckobs
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effect of decreased diffusion coefficient of the nanoparticle 
relative to that of the dye-coupled antibody (through the 
parameter kD in equation 5). The effect was not, however, as great 
as that seen for the increase in total protein loading, consistent 
with steric effects limiting access to the antibody binding sites28. 5 
The fitted rate constant kobs  (Fig. 5A) varied only slightly with 
the generation number of the dendrimer and was, within the 
experimental uncertainty, the same for the dye-labelled and NP-
labelled antibodies.  It is justified below that konc << koff so that 
kobs≈koff. The lack of variation with dendrimer generation number  10 
 
 
 
 
 
 
 20 
 
 
 
Fig. 5 (A) Rate constants for the surface-capture reaction.       : binding rate kon relative to the value for the antibody coupled directly to the fluorescent dye 
(F8-DY645);      : fitted reaction rate constant, kobs  ≈ koff ; (B) – signal/background for the surface capture reaction. : Fluorescence due to non-specific 25 
binding, relative to that found for the antibody coupled directly to the fluorescent dye (F8-DY645), Ioffset, rel ;   saturation fluorescence 
relative to the non-specific binding, (Ilim,rel - Ioffset)/Ioffset 
is as expected from the introductory theoretical discussion. The 
observed ‘off’ rate is consistent with literature values for 30 
pentameric CRP – antibody interactions (10-4 – 10-5s-1)23-25. The 
surface binding equilibrium constant, KL, obtained from fitting of 
a Langmuir isotherm to the equilibrium adsorption of the 
molecular dye-labelled antibody, gives the ratio KL = kon / koff for 
this antibody.  Hence, using the mean estimate for koff = (7.4 ± 35 
1.6) × 10-5s-1 gives for this antibody kon = 70 ± 20 M-1s-1.  
Literature values for ScFv antibodies interacting with pentameric 
CRP are typically kon ~ 2 × 104 M-1s-1 24. The discrepancy can be 
resolved through consideration of equation 5. The key factor is 
the fraction of the antigen loaded onto the capture plate surface 40 
that is active for reaction: θS. In the literature, the capture surface 
was prepared by adsorbing streptavidin first, followed by 
biotinylated antibody. It is not surprising that the value of θS 
achieved by this procedure should be the factor of 102 greater 
than that obtained as a consequence of the simple adsorption 45 
protocol that we have employed, that is implied by the relative 
values of kon.  The ‘on’ rate constants for the sensitised particles 
can be calculated, given the relative rate constants deduced from 
the capture kinetics. The values are given in Table 1. The 
estimated errors accumulate through the calculations so are 50 
significantly larger than those for the relative rate constants.  The 
deduced values for the product konc are at most 10-7s-1, justifying 
the assumption konc << koff used to identify kobs with koff. 
The other important characteristic of the labels to consider for use 
in an assay is the ratio of signal to background: in this case, the 55 
ratio of the equilibrium fluorescence (offset corrected) to the non-
specific offset (Fig. 5B).  Again, a significant advantage is noted 
for the NP-labelled antibodies. The offset was not affected and, 
indeed, may have been reduced.  The signal was significantly 
enhanced so the relative value of signal/non-specific background 60 
was increased by a factor of 3 – 7 as a consequence of the use of 
the dendrimer-sensitised NPs as the label. 
The reactivity of the NP-labelled antibodies can also be 
determined by measurement of the aggregation induced by the 
addition of the penta-valent CRP antigen to the antibody-65 
activated particle dispersion. This determination has the 
advantage of studying the particle chemistry alone, independent 
of any capture plate sensitisation protocol. We used a dynamic 
light scattering (DLS) measurement34, 35 to determine average 
cluster volume as a function of time following the introduction of 70 
the antigen as depicted on Fig. 1 36, and hence compare the 
reactivity of NPs activated with the different dendrimer linkers. 
The measurement also gave some further information concerning 
the antibody-antigen reaction, in particular the parameter ε, the 
reaction efficiency, in equation 5.  75 
In general, there are two types of aggregation.37, 38  
• Diffusion-limited aggregation - aggregation where 
there is no barrier, interpreted as ε =1 :  the average 
cluster size (mass or volume) increases linearly with 
time. Cluster mass distribution is flat up to a 80 
characteristic value then decreases exponentially.  
• Reaction limited aggregation - aggregation where there 
is some barrier, interpreted as ε < 1: the rate is 
determined by a rate constant to surmount the barrier.  
The rate is also dependent on the surface concentration 85 
of reactive sites, which grows rapidly as the cluster 
expands. Average cluster size increases exponentially 
with time. Cluster mass distribution proceeds as M/Mtot 
~ M-3/2 and its theoretical behaviour is illustrated as a 
dashed line in Fig. 6, with an indication of the expected 90 
slope.38, 39    
Figure 6 and 7 illustrate that the G3.5- and G4.5-functionalised 
particles showed the general characteristics of reaction-limited 
aggregation in the presence of CRP.  The literature values for 
association rate constants (~104 M-1s-1) 24 are relatively small and 95 
would indeed be consistent with the presence of a barrier to 
A B 
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Fig. 6 Evolution of particle volume distribution with time in the CRP-
induced aggregation of anti-CRP sensitised dendrimer G4.5-linked 
nanoparticles 
reaction. The aggregation rate constant for the G4.5 particles was 
some 5.6 times greater than for the G3.5 particles.  The 5 
exponential increase of average cluster volume with time, in the 
reaction-limited aggregation of antibody-conjugated NPs in the 
presence of CRP antigen, can be described in terms of the 
probability of capture of antigen onto the surface of a NP or onto 
a NP at the outside of a cluster, times the probability that this site 10 
will collide with an active site on another NP or cluster. Thus, the 
rate constant for average cluster volume should increase 
approximately as (θP)2 for a given initial concentration of NPs 
and antigen. Therefore, the aggregation rate enhancement for the 
G4.5 NPs compared with the G3.5 NPs implies θP for the G4.5 15 
NPs to be about twice that of the G3.5 NPs. This effect is indeed 
consistent with the increase in protein loading indicated in figure 
3, but is rather greater than that observed for the surface capture 
FLISA, for which the capture rate enhancement (Fig. 5A) was 
about 30%. A plausible explanation is that the steric constraints 20 
for capture of a NP by the antigen adsorbed onto the microtitre 
plate were significantly greater than for the antigen-mediated NP 
aggregation in solution. 
Conclusions 
Overall, the potential of dye-doped NPs as new generation labels 25 
can be realized only if the biomolecule in question is immobilised 
at the appropriate surface density while maintaining its activity. 
Moreover, the measured signal should be maximised relative to 
noise and background contributions, which in antibody-based 
assays, is dependant on the background response from the non-30 
specific absorption. In this communication, we have 
demonstrated how the use of PAMAM dendrimers as multivalent 
linkers effectively controls and maximises the active fraction of 
the particle surface. PAMAM dendrimers have been 
demonstrated as efficient coupling agents to conjugate antibodies 35 
to the surface of dye-doped silica nanoparticles. An antigen-
induced aggregation and a direct binding FLISA were used to 
demonstrate the effect of the growing number of terminal 
functional groups of the dendrimers on the resulting assay rate. 
The protein binding capacity of the dendrimer-sensitised NPs 40 
increased by the same factor as the number of surface carboxylate 
groups on the dendrimer used.  The reaction rate in an antigen- 
 
Fig. 7 Time evolution of the volume-average aggregate size time in the 
CRP-induced aggregation of anti-CRP sensitised dendrimer linked 45 
nanoparticles. G3.5 linker:  ; G4.5 linker:  . The exponential increase 
with time is as expected for reaction-limited aggregation. 
induced aggregation also increased by the same factor.  The 
reaction rate and signal enhancement in a surface capture 
immunoassay, resulting from the use of dendrimers as linkers, 50 
was significant but less than that found for antigen-induced 
aggregation, the effect being plausibly attributed to steric effects 
limiting the efficiency of the surface capture reaction. The highest 
generation of the PAMAM dendrimers (G4.5) used in this study 
showed the highest surface binding rate and the highest signal in 55 
the direct binding FLISA. The effect of increased active antibody 
loading significantly outweighed any effect of a decreased NP 
diffusion coefficient compared to that of a molecular dye-labelled 
antibody.  The practically important parameter, the ratio of the 
equilibrium fluorescence (offset corrected) to the non-specific 60 
offset, or signal to background ratio, increased by a factor of ~4 
for the G4.5 dendrimer-conjugated NPs compared to the 
molecular dye-labelled antibody. 
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